Radium-223 Plus Enzalutamide Ups Survival in Prostate Cancer

Combining radium-223 with enzalutamide offered a survival benefit in metastatic castration-resistant prostate cancer, but experts questioned its relevance in a shifting treatment landscape.
Medscape Medical News

source https://www.medscape.com/viewarticle/radium-223-plus-enzalutamideups-survival-metastatic-prostate-2024a1000gt4?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?